Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

September 1, 2026

Study Completion Date

December 1, 2026

Conditions
Major Depressive DisorderBipolar Depression
Interventions
DRUG

Xenon

The investigators have chosen to use as a maximum concentration about half the general anesthetic partial pressure of xenon (35%=70%/2) to achieve a dose that is sub-anesthetic. This concentration of xenon is very close to that at which subjects emerging from xenon anesthesia first respond to verbal commands, commonly referred to as MAC awake.

DRUG

Nitrogen gas

nitrogen-oxygen (35:65 ratio by volume) added to treatment as usual

Trial Locations (1)

02114

RECRUITING

Dauten Family Center for Bipolar Treatment Innovation, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER